New China Life Insurance (1336.HK) Earnings Analysis

New China Life Insurance (1336.HK) next reports earnings on 2026-08-27, consensus EPS 4.27 HKD. It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E 5.56.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 1336.HK next report earnings?

Next earnings date2026-08-27
Consensus EPS estimate4.27 HKD
Revenue estimaten/a

1336.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-272.37 HKDn/an/an/a
2026-03-277.67 HKD7.65 HKD+0.3%Beat
2025-08-283.13 HKD4.7 HKD-33.4%Miss
2025-04-282.01 HKD4.49 HKD-55.2%Miss
2024-12-311.89 HKDn/an/an/a
2024-10-303.08 HKDn/an/an/a
2024-08-291.97 HKD2.34 HKD-15.8%Miss

Beat rate: 1/4 (25%) over reported quarters with consensus data.

1336.HK valuation and analyst view

Trailing P/E5.56
Trailing EPS11.828 HKD
Price / book1.66
Dividend yield4.05%
Market cap194.14B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is New China Life Insurance (1336.HK)'s next earnings date?

New China Life Insurance is next scheduled to report on 2026-08-27, with a consensus EPS estimate of 4.27 HKD.

Did 1336.HK beat earnings last quarter?

Consensus estimate data was not available for 1336.HK's 2026-04-27 report.

What is 1336.HK's earnings track record?

Over the last 4 reported quarters with consensus data, 1336.HK beat estimates 1 times (25%).

What is 1336.HK's current P/E ratio and EPS?

1336.HK trades at a trailing P/E of 5.56 on trailing EPS of 11.827884615384615 HKD.

What do analysts rate 1336.HK?

1336.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.